Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00872_DB08816_nanopub.RAJbjSZKYVgB8g4H6KNLMO0XVJe-WCvcH9-8h_q4H7IMg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00872_DB08816 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00872_DB08816 label "DDI between Conivaptan and Ticagrelor - CYP3A4 Inhibitors (Strong) such as conivaptan may decrease serum concentrations of the active metabolite(s) of Ticagrelor. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Ticagrelor. Avoid use of ticagrelor in combination with strong CYP3A4 inhibitors. [drugbank_resource:DB00872_DB08816]" assertion.
- drugbank_resource:DB00872_DB08816 identifier "drugbank_resource:DB00872_DB08816" assertion.
- drugbank_resource:DB00872_DB08816 title "DDI between Conivaptan and Ticagrelor - CYP3A4 Inhibitors (Strong) such as conivaptan may decrease serum concentrations of the active metabolite(s) of Ticagrelor. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Ticagrelor. Avoid use of ticagrelor in combination with strong CYP3A4 inhibitors." assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB08816 assertion.
- drugbank:DB08816 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB08816 assertion.